| Dr Michelle Burnside Fowers, MD | |
|
400 W Ih 635 Fwy, Suite 250, Irving, TX 75063-3718 | |
| (972) 481-6400 | |
| (972) 831-9794 |
| Full Name | Dr Michelle Burnside Fowers |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 400 W Ih 635 Fwy, Irving, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043243744 | NPI | - | NPPES |
| 151910001 | Medicaid | TX | |
| 8F3458 | Other | TX | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | L3302 (Texas) | Primary |
| Entity Name | Healthtexas Provider Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760488936 PECOS PAC ID: 1355254210 Enrollment ID: O20040727001187 |
News Archive
Magellan Health Services, a specialty health care management organization with deep ties to the Columbia, Maryland area, today announced that, in response to the shooting at The Mall in Columbia, it has set up a 24-hour toll-free hotline for individuals to access, regardless of whether or not they are Magellan members.
A technology developed by scientists at Lawrence Berkeley National Laboratory (Berkeley Lab) shows great promise for diagnosing Alzheimer's disease before symptoms arise, potentially changing the course of research and treatment for this condition, which affects millions of people worldwide and is estimated to be the sixth leading cause of death in the United States.
Stem cells are versatile all-rounders. In the medical field, high hopes are resting on these miracle workers. However, we still understand very little about them.
Dicerna Pharmaceuticals, Inc., (Dicerna) a second generation RNA interference (RNAi) company developing novel therapeutics utilizing its proprietary Dicer Substrate Technology™ and Dicer Substrate siRNA (DsiRNA) molecules, and Kyowa Hakko Kirin Co., Ltd. (Kyowa Hakko Kirin), one of Japan's leading biopharmaceutical companies, announced today that the two companies have entered into a research collaboration and license agreement for the research, development and commercialization of drug delivery systems and DsiRNA pharmaceuticals for therapeutic targets in oncology.
The international research & development (R&D) consortium, AfriCoLeish, formed by six research organizations from East Africa and Europe, has launched a Phase III clinical study to address the extreme difficulty in treating visceral leishmaniasis (VL) in patients who also are HIV-positive.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michelle Burnside Fowers, MD 400 W Ih 635 Fwy, Suite 250, Irving, TX 75063-3718 Ph: (972) 481-6400 | Dr Michelle Burnside Fowers, MD 400 W Ih 635 Fwy, Suite 250, Irving, TX 75063-3718 Ph: (972) 481-6400 |
News Archive
Magellan Health Services, a specialty health care management organization with deep ties to the Columbia, Maryland area, today announced that, in response to the shooting at The Mall in Columbia, it has set up a 24-hour toll-free hotline for individuals to access, regardless of whether or not they are Magellan members.
A technology developed by scientists at Lawrence Berkeley National Laboratory (Berkeley Lab) shows great promise for diagnosing Alzheimer's disease before symptoms arise, potentially changing the course of research and treatment for this condition, which affects millions of people worldwide and is estimated to be the sixth leading cause of death in the United States.
Stem cells are versatile all-rounders. In the medical field, high hopes are resting on these miracle workers. However, we still understand very little about them.
Dicerna Pharmaceuticals, Inc., (Dicerna) a second generation RNA interference (RNAi) company developing novel therapeutics utilizing its proprietary Dicer Substrate Technology™ and Dicer Substrate siRNA (DsiRNA) molecules, and Kyowa Hakko Kirin Co., Ltd. (Kyowa Hakko Kirin), one of Japan's leading biopharmaceutical companies, announced today that the two companies have entered into a research collaboration and license agreement for the research, development and commercialization of drug delivery systems and DsiRNA pharmaceuticals for therapeutic targets in oncology.
The international research & development (R&D) consortium, AfriCoLeish, formed by six research organizations from East Africa and Europe, has launched a Phase III clinical study to address the extreme difficulty in treating visceral leishmaniasis (VL) in patients who also are HIV-positive.
› Verified 2 days ago
Vicky R Taylor, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 6724 Verde #228, Irving, TX 75039 Phone: 972-978-7473 | |
Joan P Kay, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 2021 N Macarthur Blvd, Suite 250, Irving, TX 75061 Phone: 972-253-4310 Fax: 972-253-4326 | |
Dr. Satish Goel, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 8850 N. Macarthur Boulevard, 102, Irving, TX 75766 Phone: 972-444-8632 Fax: 972-444-8691 | |
Darlene Annie Kurian, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 6750 N Macarthur Blvd, Ste 206, Irving, TX 75039 Phone: 972-253-4345 Fax: 972-253-6425 | |
Hiren Anil Patel, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 204 Seva Ct, Irving, TX 75061 Phone: 121-499-8632 | |
Agboola O Fatiregun, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 3501 N Macarthur Blvd Ste 450, Irving, TX 75062 Phone: 972-786-0330 Fax: 972-739-2894 |